摘要 |
The present invention provides for a method of increasing anti-NeuGc antibody level in the blood of an animal by either intravenous injection of autogenic or allogeneic cells, wherein the cells contain NeuGc on their plasma membrane, or oral administration of NeuGc-containing substance from animal tissues. This method may be applied to the immunoprevention of humans who have a higher risk of developing cancer or the prevention of recurrence in cancer patients who have had therapeutic treatment. This method may further be applied to the immunoprevention of chickens at risk of developing Marek's Disease. |